Effect of 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, on clinical recurrences of ocular herpetic keratitis in squirrel monkeys
- 31 October 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 33 (1) , 65-72
- https://doi.org/10.1016/s0166-3542(96)00997-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in miceAntiviral Research, 1996
- A Prospective Randomized Trial of Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex KeratitisCornea, 1994
- Introduction: The First Effective AntiviralPublished by Springer Nature ,1993
- Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpesAntimicrobial Agents and Chemotherapy, 1992
- Acyclovir prophylaxis for herpes simplex virus infectionAntimicrobial Agents and Chemotherapy, 1987
- Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration.British Journal of Ophthalmology, 1986
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- A Trial of Topical Acyclovir in Genital Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1982
- IDU and Hydrocortisone in Experimental Herpes Simplex KeratitisArchives of Ophthalmology (1950), 1962
- Clinical Cure of Herpes Simplex Keratitis by 5-Iodo-2'-DeoxyuridineExperimental Biology and Medicine, 1962